Ferro sells fine chemicals arm to private equity
US company Ferro has said it will sell off its fine chemicals division to private equity firm Arsenal Capital Partners, which will rename the business as Novolyte Technologies, for $66m.
Archives for October 13, 2008
WuXi misses Q3 goals due to “drop in R&D spending”
China’s WuXi PharmaTech has reported a below par set of unaudited third quarter results and has cut its full-year expectations blaming the current economic climate’s impact on R&D spending within the sector.
FDA issues guidance in CGT potency tests
Draft guidance for testing the potency of cellular and gene therapy products (CGTs) has been issued by the US Food and Drug Administration (FDA).
Artel's QA/QC services driving expansion
With big pharma and biopharma looking to cut costs and increase efficiency, liquid handling experts Artel have found that their services are in greater need than ever before.
PPD yo-yos on alogliptin delay
Contract research organisation PPD will have to forego a scheduled $25m payment from Takeda of Japan in the fourth quarter after the US Food and Drug Administration (FDA) held up approval of a product for diabetes.
Drug delivery round-up: News in brief
in-PharmaTechnologist.com presents its latest round up of developments in drug delivery, including Philips first foray into drug delivery and a licensing deal for 3M.
Applied Biosystems' rapid Mycoplasma detection kit
The MicroSEQ detection platform, developed by Applied Biosystems, looks set to revolutionise the detection of bacterial Mycoplasma in industrial scale biopharmaceutical manufacturing.